Liontrust Investment Partners LLP Has $12.94 Million Stock Position in UnitedHealth Group Incorporated $UNH

Liontrust Investment Partners LLP increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,472 shares of the healthcare conglomerate's stock after purchasing an additional 3,034 shares during the period. Liontrust Investment Partners LLP's holdings in UnitedHealth Group were worth $12,938,000 at the end of the most recent reporting period.Get UnitedHealth Group alerts:The Top 3 Investment Themes That Will Dominate 2026Other hedge funds have also made changes to their positions in the company. Caitlin John LLC boosted its position in shares of UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after acquiring an additional 111 shares in the last quarter. Murphy Pohlad Asset Management LLC grew its stake in shares of UnitedHealth Group by 21.8% in the 2nd quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate's stock valued at $1,380,000 after purchasing an additional 791 shares during the period. Triumph Capital Management bought a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $1,324,000. Wealth Effects LLC grew its position in UnitedHealth Group by 14.4% in the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock valued at $1,463,000 after acquiring an additional 591 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of UnitedHealth Group by 48.9% during the second quarter. EverSource Wealth Advisors LLC now owns 5,790 shares of the healthcare conglomerate's stock valued at $1,806,000 after acquiring an additional 1,901 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock. UnitedHealth Group Stock PerformanceUNH stock opened at $341.83 on Friday. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The business's fifty day moving average is $339.84 and its 200-day moving average is $317.07. The company has a market cap of $309.65 billion, a P/E ratio of 17.84, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43. 5 Healthcare Names to Watch as Sector Rotation Is in Full SwingUnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts' consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm's revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $7.15 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year. UnitedHealth Group Dividend AnnouncementThe company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group's dividend payout ratio (DPR) is 46.14%. Wall Street Analyst Weigh InSnowflake Stock Is on Fire—It’s Still Not Too Late to BuyA number of research firms have commented on UNH. Mizuho boosted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an "outperform" rating in a research report on Thursday, October 9th. Sanford C. Bernstein increased their price target on UnitedHealth Group from $433.00 to $440.00 and gave the stock an "outperform" rating in a research report on Thursday, October 30th. JPMorgan Chase & Co. boosted their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the stock an "overweight" rating in a research note on Thursday, October 9th. Jefferies Financial Group raised their target price on UnitedHealth Group from $317.00 to $409.00 and gave the company a "buy" rating in a research note on Friday, October 17th. Finally, Barclays increased their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an "overweight" rating in a report on Thursday, October 9th. Seventeen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $385.54.Get Our Latest Analysis on UNHUnitedHealth Group Company Profile (Free Report)UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.See AlsoFive stocks we like better than UnitedHealth GroupHow the NYSE and NASDAQ are Different, Why That Matters to InvestorsDisney's $1 Billion Deal Brings Its Magic to OpenAIBest of the list of Dividend Aristocrats: Build wealth with the aristocrat indexWhy Amazon Could Be a $300 Stock Within WeeksDividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors UpsideThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in UnitedHealth Group Right Now?Before you consider UnitedHealth Group, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here